JOB S SYNDROME

Clinical trials for JOB S SYNDROME explained in plain language.

Never miss a new study

Get alerted when new JOB S SYNDROME trials appear

Sign up with your email to follow new studies for JOB S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a common arthritis drug tame rare immune disease symptoms?

Disease control Recruiting now

This early study tests baricitinib, a drug already approved for other immune conditions, in 20 people with Job syndrome who also have lupus-like disease or eczema. Participants take the pill daily for 6 months. The main goal is to see if it is safe and tolerable, while also check…

Matched conditions: JOB S SYNDROME

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

JOB S SYNDROME

Get alerted when new JOB S SYNDROME trials appear

Could a common arthritis drug tame rare immune disease symptoms?